Advaxis, Inc.
The Technology Centre of New Jersey
675 U.S. Route One, South
North Brunswick
New Jersey
08902
United States
Tel: 732-545-1590
Fax: 732-545-1084
Website: http://www.advaxis.com/
About Advaxis, Inc.
Advaxis is a clinical-stage biotechnology company developing cancer immunotherapies that enlist the body’s own immune system to fight cancer.YEAR FOUNDED:
2002
LEADERSHIP:
CEO: Daniel O’Connor
CFO: Sara Bonstein
CSO (Scientific): Robert Petit
JOBS:
Please click here for Advaxis job opportunities.
CLINICAL TRIAL:
Please click here for clinical trial information.
FOLLOW ADVAXIS:
Tweets by Advaxis
539 articles about Advaxis, Inc.
-
Advaxis, Inc. Science & Operations Officer Moderates Live Vaccine Panel at Cancer Drug Research Conference
1/28/2011
-
Advaxis, Inc.: Independent Data Safety Monitoring Board Gives “Go-Ahead” to Complete Dosing in First Leg of Advaxis’ Phase II Cervical Dysplasia Trial
1/14/2011
-
Advaxis, Inc.' Senior Science Team and Head Clinician to Participate in Science Update Conference Call
12/16/2010
-
Advaxis, Inc. 2010 Science Update Conference Call
12/14/2010
-
Advaxis, Inc. India Cervix Cancer Trial Begins Dosing
11/24/2010
-
Advaxis, Inc. Granted a Qualifying Therapeutic Discovery Project Credit Totaling $244,479 for Advaxis' Lead Construct Candidate ADXS11-001
11/11/2010
-
Advaxis, Inc. Enters into Collaboration with the University of British Columbia
11/8/2010
-
Advaxis, Inc. to Present at the Fifth Annual Singular Research "Best of the Uncovereds" Conference
11/2/2010
-
Advaxis Signs CRADA with Vaccine Branch of National Cancer Institute
10/29/2010
-
Advaxis, Inc. Completes Recruitment of First 11 Patients in US Cervical Dysplasia Study
10/22/2010
-
Dr. Robert Petit Joins Advaxis, Inc. as V.P. of Clinical Operations
10/12/2010
-
Advaxis, Inc. to Present at the 9th Annual Biotechnology Industry Organization (BIO) Investor Forum Conference
10/1/2010
-
Advaxis, Inc. Investor Conference Call Summary
10/1/2010
-
Advaxis, Inc. Chairman and CEO Issues Statement to Shareholders
9/27/2010
-
India Approves Advaxis, Inc. Trial in Cervix Cancer
9/23/2010
-
Advaxis, Inc. Chairman/CEO Thomas A. Moore Outlined Strategic Plan at the 2010 Rodman & Renshaw Global Healthcare Conference
9/16/2010
-
Advaxis, Inc. Publishes Research on New Her2 Vaccine
9/13/2010
-
U.S. Patent and Trademark Office Approves Patent Application That Extends Advaxis, Inc. Technology to Include HER2/neu for Use in Listeria and Proten Vaccines
9/8/2010
-
European Patent Office Allows Advaxis, Inc./University of Pennsylvania Modified LLO Patent
8/24/2010
-
U.S. Patent & Trademark Office to Allow for New Advaxis, Inc. Patent
8/20/2010